DLG-41 is a GAS41 YEATS domain inhibitor ( IC50: 600 nM in AlphaLISA). DLG-41 potently disrupts the association of GAS41 YEATS with chromatin in cells. DLG-41 strongly enhances levels of CDKN1A. DLG-41 has anticancer activity against NSCLC [1].
References:
[1]. Listunov D, et al. Discovery and Development of a Small-Molecule Inhibitor Targeting the GAS41 YEATS Domain in Nonsmall Cell Lung Cancer. J Med Chem. 2025 Dec 11;68(23):25324-25351.
References:
[1]. Listunov D, et al. Discovery and Development of a Small-Molecule Inhibitor Targeting the GAS41 YEATS Domain in Nonsmall Cell Lung Cancer. J Med Chem. 2025 Dec 11;68(23):25324-25351.
















